Blood Collection Tubes for Liquid Biopsy Sales Set to Grow at 12% through 2021: Fact.MR
NEW YORK, March 11, 2021 /PRNewswire/ Fact.MR is conducting an ongoing research study on the blood collection tubes for liquid biopsy market. As per its findings, a positive growth outlook is expected for 2021, primarily underpinned by increasing technological advancements and increasing R&D activities from the government. Growth prospects for the upcoming decade are also optimistic, registering a noteworthy expansion rate until 2031.
According to Fact.MR, the market is poised to benefit immensely from the rising usage of CTCs and ctDNA for liquid biopsy applications. According to National Center for Health Statistics, in 2021, 1.8 million new cancer cases are projected to occur in the U.S., surging the sales for blood collection tubes for liquid biopsy.
Peripheral Artery Revascularization Demand Propelled by Increasing Prevalence of Peripheral Artery Disease, Says Fact MR biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.